Evidence map›Paper›PMID 41368309›Full record

ReviewFrontiers in medicine2025

Lung cancer and the Gut-microbiota-lung Axis: emerging evidence and potential clinical implications.

Li Liu, Li Yang, Hongdu Zhang, Hongmin Li, Tianlu Shang, Lihan Liu

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li LiuDepartment of thoracic surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.
Li YangDepartment of Oncology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.
Hongdu ZhangDepartment of thoracic surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.
Hongmin LiDepartment of thoracic surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.
Tianlu ShangDepartment of thoracic surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.
Lihan LiuDepartment of thoracic surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the leading cause of cancer-related deaths globally, with a 5-years survival rate of only around 20%. Merging cohort and Mendelian-randomization studies indicate that gut dysbiosis is associated with-though not yet proven to cause-an elevated risk and worse prognosis of non-small-cell lung cancer. Lower fecal abundance of butyrate producers such as

Indexed as

gut dysbiosisgut microbiotaGut-microbiota-lung Axisimmunotherapylung cancershort-chain fatty acids

Identifiers

PMID41368309
PMCPMC12682795

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.